Therapeutics for Diabetes and Catabolic Disorders: Pt. 2: Oral Hypoglycemics

This is Part 2 of a presentation by Duncan C. Ferguson, VMD, PhD, DACVIM, DACVCP on February 12, 2026 about new endocrine therapeutics as part of the American College of Veterinary Clinical Pharmacology (ACVCP)/European College of Veterinary Pharmacology and Toxicology (ECVPT) residency training seminar series. This part focuses on types of the oral hypoglycemics including sulfonylureas, thiazolidinediones, and Sodium-Glucose Transport 2 (SGLT2) Inhibitors.. Presented by ACVCP, ECVPT and VetMedAcademy.org. For additional videos on this topic and learning materials, please register with VetMedAcademy at https://vetmedacademy.org